fbpx

Eye Cancer therapy in the form of the first indigenous Ruthenium-106

  • IASbaba
  • December 31, 2020
  • 0
UPSC Articles
Print Friendly, PDF & Email

Eye Cancer therapy in the form of the first indigenous Ruthenium-106

Part of: GS Prelims and GS-III – Sci & Tech

In news 

  • Bhabha Atomic Research Centre (BARC), Mumbai has developed Eye Cancer therapy in the form of the first indigenous Ruthenium 106 Plaque for treatment of Ocular Tumours.

Key takeaways 

  • The handling of plaque is very convenient for the Surgeon and it has been acknowledged to be at par with the international standards.
  • So far the BARC plaques made in India through the Department of Atomic Energy have been used for seven cases for Ocular Cancer.
  • Ocular tumours are tumours inside the eye. They are collections of cells that grow and multiply abnormally and form masses.

Important value additions 

Ruthenium-106

  • Ruthenium-106 is a radioactive form of the rare heavy metal ruthenium, which is a “platinum group” metal similar to platinum.
  • Ruthenium-106 is produced from the fission or splitting of uranium-235, the type of uranium used in nuclear fission reactors, so it’s found in spent nuclear fuel.
  • It’s used in medicine for cancer radiation therapy, especially for eye and skin tumours.
  • It’s also used in radioisotope thermoelectric generators that power satellites.

For a dedicated peer group, Motivation & Quick updates, Join our official telegram channel – https://t.me/IASbabaOfficialAccount

Search now.....